Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling